Models (1)
———
Structure-based drug design model generating 3D ligands in protein pockets under gradient guidance for affinity, synthesizability, and selectivity.
Small moleculeProtein
Structure-based drug design model generating 3D ligands in protein pockets under gradient guidance for affinity, synthesizability, and selectivity.